Armistice Capital takes beneficial ownership stake above five percent in Intelligent Bio Solutions
Intelligent Bio Solutions Inc. closed 21.66% higher at $3.3700 on August 17, after Armistice Capital, LLC filed an amended Schedule 13G — a beneficial ownership disclosure required of passive investors holding more than 5% of a company's shares — with the Securities and Exchange